CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+12.51%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.53B
AUM Growth
+$1.53B
(+28%)
Cap. Flow
+$150M
Cap. Flow
% of AUM
9.78%
Top 10 Holdings %
Top 10 Hldgs %
64.78%
Holding
37
New
12
Increased
6
Reduced
7
Closed
3
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$98.1M |
| 2 |
Universal Health Services
UHS
|
$88.4M |
| 3 |
GSK
GSK
|
$53.2M |
| 4 |
MDCO
Medicines Co
MDCO
|
$43.7M |
| 5 |
HCA Healthcare
HCA
|
$39.5M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$110M |
| 2 |
Perrigo
PRGO
|
$82.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$61.2M |
| 4 |
Orthofix Medical
OFIX
|
$47.9M |
| 5 |
Gilead Sciences
GILD
|
$40.5M |
Sector Composition
| 1 | Healthcare | 82.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Nektar Therapeutics
NKTR
$568M
| $200M | 9.79% | 3,350,000 -1,850,000 | -36% | -$110M |
|
|
2
HCA Healthcare
HCA
$94.5B
| $110M | 5.37% | 1,250,000 +450,000 | +56% | +$39.5M |
|
3
Viatris
VTRS
$12.3B
| $106M | 5.18% | 2,500,000 -200,000 | -7% | -$8.46M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $98.1M | 4.8% | +600,000 | New | +$98.1M |
|
|
5
Universal Health Services
UHS
$11.6B
| $88.4M | 4.33% | +780,000 | New | +$88.4M |
|
6
Tenet Healthcare
THC
$16.3B
| $87.2M | 4.27% | 5,750,000 | – | – |
|
|
EVHC
7
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $86.4M | 4.23% | 2,500,000 +1,000,000 | +67% | +$34.6M |
|
|
GHDX
8
DELISTED
Genomic Health, Inc.
GHDX
| $84.1M | 4.11% | 2,458,100 | – | – |
|
|
TSRO
9
DELISTED
TESARO, Inc.
TSRO
| $70.4M | 3.45% | 850,000 +450,000 | +113% | +$37.3M |
|
10
Brookdale Senior Living
BKD
$1.83B
| $63.1M | 3.09% | 6,500,000 +1,100,000 | +20% | +$10.7M |
|
|
BIVV
11
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $59.1M | 2.89% | 1,096,000 +96,000 | +10% | +$5.18M |
|
|
12
GSK
GSK
$79.9B
| $53.2M | 2.6% | +1,500,000 | New | +$53.2M |
|
13
Myriad Genetics
MYGN
$593M
| $51.5M | 2.52% | 1,500,000 -500,000 | -25% | -$17.2M |
|
|
MDCO
14
DELISTED
Medicines Co
MDCO
| $43.7M | 2.14% | +1,600,000 | New | +$43.7M |
|
|
ELGX
15
DELISTED
Endologix Inc
ELGX
| $42.8M | 2.09% | 8,000,000 | – | – |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $40.8M | 2% | 600,000 +400,000 | +200% | +$27.2M |
|
|
AMAG
17
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $35.1M | 1.72% | 2,650,000 | – | – |
|
|
RDUS
18
DELISTED
Radius Health, Inc.
RDUS
| $31.8M | 1.56% | 1,000,000 -150,000 | -13% | -$4.77M |
|
|
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $31.5M | 1.54% | +800,000 | New | +$31.5M |
|
|
20
Orthofix Medical
OFIX
$592M
| $27.4M | 1.34% | 500,000 -875,000 | -64% | -$47.9M |
|
21
Alkermes
ALKS
$4.78B
| $21.9M | 1.07% | +400,000 | New | +$21.9M |
|
|
NVTA
22
DELISTED
Invitae Corporation
NVTA
| $21.8M | 1.07% | 2,398,123 | – | – |
|
|
23
Sarepta Therapeutics
SRPT
$1.78B
| $16.7M | 0.82% | 300,000 -1,100,000 | -79% | -$61.2M |
|
|
KTWO
24
DELISTED
K2M Group Holdings, Inc
KTWO
| $15.3M | 0.75% | +850,000 | New | +$15.3M |
|
|
WMGI
25
DELISTED
Wright Medical Group Inc
WMGI
| $12.8M | 0.62% | +575,000 | New | +$12.8M |
|